Iron chelation in the treatment of neurodegenerative diseases
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F16%3A10328117" target="_blank" >RIV/00216208:11110/16:10328117 - isvavai.cz</a>
Alternative codes found
RIV/00064165:_____/16:10328117
Result on the web
<a href="http://dx.doi.org/10.1016/j.jtemb.2016.03.010" target="_blank" >http://dx.doi.org/10.1016/j.jtemb.2016.03.010</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.jtemb.2016.03.010" target="_blank" >10.1016/j.jtemb.2016.03.010</a>
Alternative languages
Result language
angličtina
Original language name
Iron chelation in the treatment of neurodegenerative diseases
Original language description
Disturbance of cerebral iron regulation is almost universal in neurodegenerative disorders. There is a growing body of evidence that increased iron deposits may contribute to degenerative changes. Thus, the effect of iron chelation therapy has been investigated in many neurological disorders including rare genetic syndromes with neurodegeneration with brain iron accumulation as well as common sporadic disorders such as Parkinson's disease, Alzheimer's disease, and multiple sclerosis. This review summarizes recent advances in understanding the role of iron in the etiology of neurodegeneration. Outcomes of studies investigating the effect of iron chelation therapy in neurodegenerative disorders are systematically presented in tables. Iron chelators, particularly the blood brain barrier-crossing compound deferiprone, are capable of decreasing cerebral iron in areas with abnormally high concentrations as documented by MRI. Yet, currently, there is no compelling evidence of the clinical effect of iron removal therapy on any neurological disorder. However, several studies indicate that it may prevent or slow down disease progression of several disorders such as aceruloplasminemia, pantothenate kinase-associated neurodegeneration or Parkinson's disease.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FH - Neurology, neuro-surgery, nuero-sciences
OECD FORD branch
—
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of Trace Elements in Medicine and Biology
ISSN
0946-672X
e-ISSN
—
Volume of the periodical
38
Issue of the periodical within the volume
December
Country of publishing house
DE - GERMANY
Number of pages
12
Pages from-to
81-92
UT code for WoS article
000385473600010
EID of the result in the Scopus database
2-s2.0-84992036208